Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections
Author(s) -
Alba Ruedas-López,
Isaac Alonso-García,
Cristina Lasarte-Monterrubio,
Paula Guijarro-Sánchez,
Eva Gato,
Juan Carlos Vázquez-Ucha,
Juán A. Vallejo,
Pablo A. Fraile-Ribot,
Begoña Fernández-Pérez,
David Velasco,
José María Gutiérrez-Urbón,
Marina Oviaño,
Alejandro Beceiro,
Concepción GonzálezBello,
Antonio Oliver,
Jorge Arca-Suárez,
Germán Bou
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02067-21
Subject(s) - ceftazidime/avibactam , pseudomonas aeruginosa , ceftazidime , tazobactam , microbiology and biotechnology , avibactam , drug resistance , medicine , beta lactamase inhibitors , biology , antibiotics , antibiotic resistance , bacteria , imipenem , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom